The disease must appear in a defined population * The population must be identifiable * The disease must present a health problem * There must be an effective treatment for the disease * Screening must be cost effective in financial terms and concerning quality of life
No takes yet. Share an insight, caveat, or question.
Eva M. Kohner (1993) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: